Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells

Artificial Organs

Volumn 34, Issue 6, 2010, Pages 453-461

  Kim, Yong Sook ^a   Kwon, Jin Sook ^a   Hong, Moon Hwa ^a   Kim, Jin ^b   Song, Chang Hun ^b   Jeong, Myung Ho ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Kang, Jung Chae ^a   Ahn, Youngkeun ^a  

^a Chonnam National University Medical School   (South Korea)

^b JB Stem Cell Institute Inc ^*  (South Korea)

Author keywords

Matrix metalloproteinase 2; Mesenchymal stem cells; Migration; Myocardial infarction; Oxytocin

Indexed keywords

CELL PROLIFERATION; ENDOTHELIAL CELLS; FLOWCHARTING; HEART; RATS; STEM CELLS;

CELL-BE; CELL/B.E; CELL/BE; ENGRAFTMENT; MATRIX METALLOPROTEINASE-2; MESENCHYMAL STEM CELL; MIGRATION; MYOCARDIAL INFARCTION; OXYTOCIN; TUBE FORMATION;

CELL CULTURE;

CONNEXIN 43; GELATINASE A; OXYTOCIN; PHOSPHATE BUFFERED SALINE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL MIGRATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DIASTOLIC BLOOD PRESSURE; ENGRAFTMENT; GENE INACTIVATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HISTOPATHOLOGY; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REPERFUSION INJURY; RNA INTERFERENCE; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTION INITIATION; UMBILICAL CORD BLOOD; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; FETUS BLOOD; GENE SILENCING; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; FETAL BLOOD; GENE KNOCKDOWN TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, SMALL INTERFERING;

EID: 77953180688     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00894.x     Document Type: Article

References (39)

1. Abbate A, Bussani R, Amin MS, Vetrovec GW, Baldi A. Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol 2006 38 : 1834 1840.
2. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001 410 : 701 705.
3. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005 115 : 572 583.
4. Melo LG, Pachori AS, Kong D, et al. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004 109 : 2386 2393.
5. Caplice NM, Deb A. Myocardial-cell replacement: the science, the clinic and the future. Nat Clin Pract 2004 1 : 90 5.
6. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 2008 314 : 1937 1944.
7. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells (Dayton, Ohio) 2003 21 : 105 110.
8. Mitchell JB, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells (Dayton, Ohio) 2006 24 : 376 385.
9. Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (Dayton, Ohio) 2008 26 : 300 311.
10. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem cells (Dayton, Ohio) 2006 24 : 1294 1301.
11. Kajstura J, Rota M, Whang B, et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005 96 : 127 137.
12. Kinnaird T, Stabile E, Burnett MS, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004 109 : 1543 1549.
13. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005 11 : 367 368.
14. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006 98 : 1076 1084.
15. Schachinger V, Erbs S, Elsasser A, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006 27 : 2775 2783.
16. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006 113 : 1287 1294.
17. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006 355 : 1222 1232. (Pubitemid 44427446)
18. Zhang D, Fan GC, Zhou X, et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 2008 44 : 281 292.
19. Kucic T, Copland IB, Cuerquis J, et al. Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia. Am J Physiol 2008 295 F488 96.
20. Okada H, Suzuki J, Futamatsu H, Maejima Y, Hirao K, Isobe M. Attenuation of autoimmune myocarditis in rats by mesenchymal stem cell transplantation through enhanced expression of hepatocyte growth factor. Int Heart J 2007 48 : 649 661.
21. Lim SY, Kim YS, Ahn Y, et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovascular Res. 2006 70 : 530 542.
22. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008 77 : 134 142.
23. Erwin GS, Crisostomo PR, Wang Y, et al. Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. J Surg Res 2009 152 : 319 324.
24. Reversi A, Cassoni P, Chini B. Oxytocin receptor signaling in myoepithelial and cancer cells. J Mammary Gland Biol Neoplasia 2005 10 : 221 229.
25. Yazawa H, Hirasawa A, Horie K, et al. Oxytocin receptors expressed and coupled to Ca2+ signalling in a human vascular smooth muscle cell line. Br J Pharmacol 1996 117 : 799 804.
26. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC. Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999 140 : 1301 1309.
27. Tribollet E, Barberis C, Dreifuss JJ, Jard S. Autoradiographic localization of vasopressin and oxytocin binding sites in rat kidney. Kidney Int. 1988 33 : 959 965.
28. Ohmichi M, Koike K, Nohara A, et al. Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 1995 136 : 2082 2087.
29. Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004 279 : 11384 11391.
30. Danalache BA, Paquin J, Donghao W, et al. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells (Dayton, Ohio) 2007 25 : 679 688.
31. Cattaneo MG, Chini B, Vicentini LM. Oxytocin stimulates migration and invasion in human endothelial cells. Br J Pharmacol 2008 153 : 728 736.
32. Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells (Dayton, Ohio) 2007 25 : 1737 1745.
33. Nagata J, Kijima H, Hatanaka H, et al. Angiopoietin-1 and vascular endothelial growth factor expression in human esophageal cancer. Int J Mol Med 2002 10 : 423 426.
34. De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, et al. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 2007 92 : 440 449.
35. Cho PS, Messina DJ, Hirsh EL, et al. Immunogenicity of umbilical cord tissue derived cells. Blood 2008 111 : 430 438.
36. Steingen C, Brenig F, Baumgartner L, Schmidt J, Schmidt A, Bloch W. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol 2008 44 : 1072 1084.
37. Schwartz MA, Horwitz AR. Integrating adhesion, protrusion, and contraction during cell migration. Cell 2006 125 : 1223 1225.
38. Imanishi Y, Saito A, Komoda H, et al. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol 2008 44 : 662 671.
39. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008 103 : 1204 1219.